Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology

NEXT STORY
Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M) in Combination Therapy for Ovarian Cancer
PREV STORY
Oncology Molecular Diagnostics Market 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CytomX Announces Upcoming Trials in Progress Poster Presentations at European Society for Medical Oncology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Sept. 08, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News

Bio-Path Holdings to Present Data at the 2018 AACR Annual Meeting

HOUSTON, March 15, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company ...

author_avatar
NASDAQ Market News

China Molecular Diagnostics Market, 2022 – Test Volume & Forecasts

Dublin, Sept. 13, 2017 (GLOBE NEWSWIRE) -- The "China Molecular Diagnostics Market, Test Volume ...

author_avatar
NASDAQ Market News